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Abstract
While there have been studies exploring regulatory variation in one or more tissues, the complexity of tissue-specificity in
multiple primary tissues is not yet well understood. We explore in depth the role of cis-regulatory variation in three human
tissues: lymphoblastoid cell lines (LCL), skin, and fat. The samples (156 LCL, 160 skin, 166 fat) were derived simultaneously
from a subset of well-phenotyped healthy female twins of the MuTHER resource. We discover an abundance of cis-eQTLs in
each tissue similar to previous estimates (858 or 4.7% of genes). In addition, we apply factor analysis (FA) to remove effects
of latent variables, thus more than doubling the number of our discoveries (1,822 eQTL genes). The unique study design
(Matched Co-Twin Analysis—MCTA) permits immediate replication of eQTLs using co-twins (93%–98%) and validation of
the considerable gain in eQTL discovery after FA correction. We highlight the challenges of comparing eQTLs between
tissues. After verifying previous significance threshold-based estimates of tissue-specificity, we show their limitations given
their dependency on statistical power. We propose that continuous estimates of the proportion of tissue-shared signals and
direct comparison of the magnitude of effect on the fold change in expression are essential properties that jointly provide a
biologically realistic view of tissue-specificity. Under this framework we demonstrate that 30% of eQTLs are shared among
the three tissues studied, while another 29% appear exclusively tissue-specific. However, even among the shared eQTLs, a
substantial proportion (10%–20%) have significant differences in the magnitude of fold change between genotypic classes
across tissues. Our results underline the need to account for the complexity of eQTL tissue-specificity in an effort to assess
consequences of such variants for complex traits.
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Introduction
Gene expression is an essential cellular function whose regulation
determines a significant proportion of the phenotypic variance.
Using microarrays and recently second generation sequencing
(RNA-seq) [1,2], major progress has been made in understanding
thegeneticsofhumangeneexpression and identifyinglocithatdrive
differential expression across individuals [3,4], populations [5–7]
and tissues [7–11]. This development is especially valuable for the
biological analysis of genome-wide association (GWAS) signals [12],
which often map to non-genic regions and are thus hard to interpret
in the absence of additional information [13].
Transcript abundance is a very proximal endophenotype
affected by genetic variation and has already facilitated the
identification of candidate susceptibility genes for metabolic
disease traits [14], asthma [15] or Crohn’s disease [16]. This has
been mostly possible when the tissue of expression was relevant to
the interrogated complex trait, as disease phenotypes manifest
themselves only in certain tissues. eQTLs discovered in LCLs have
primarily helped explain GWAS associations with immunity-
related disorders [17,18] while associations with obesity-related
traits were mostly observed when gene expression was quantified
in adipose tissue [9]. Nevertheless, our guess of tissue relevance is
yet far from satisfactory [19], reinforcing thus the incontestable
PLoS Genetics | www.plosgenetics.org 1 February 2011 | Volume 7 | Issue 2 | e1002003value of measuring expression in multiple cell-types (including
primary tissues reflecting in vivo patterns).
Transcriptional regulatory networks are expected to dictate
tissue-specificity of regulatory effects [20], but the extent of this is
still under debate. Depending on the cell-types compared and the
eQTL discovery methods used, current estimates for tissue-
specificity of eQTLs range from ,30% (liver, adipose tissue)
[21] to 70–80% (LCL, fibroblasts, T cells) [7].
In this study we investigated various aspects of tissue-specificity and
we emphasize the importance of accounting not only for statistical
significance but also for continuous biological properties of regulatory
variants, such as fold change in expression. We explored the
complexity of the human cis-regulatory variation landscape in three
tissues (LCL, skin and fat) derived from a subset of female Caucasian
twins aged between 40 and 87 yearsold(mean 62 years) from the UK
AdultTwin registry [22]. The present study represents the pilot phase
of the MuTHER project (Multiple Tissue Human Expression
Resource—http://www.muther.ac.uk/), a major resource initiated
to enhance our knowledge about common trait susceptibility by
providing genome-wide expression, methylation and eventually
transcriptome sequencing information for 855 extensively pheno-
typed twins (clinical, anthropometric, life-style information as well as
a wide range of biological measurements are available).
Results
Gene expression was quantified in LCL, skin and fat using
Illumina’s whole genome expression array (HumanHT-12 version 3)
containing 48,803 probes in three technical replicates [E-MTAB-
522]. Log2 - transformed expression signals were normalized
separately per tissue by quantile normalization across replicates
followed by quantile normalization across individuals. 27,499 probes
mapping uniquely to 18,170 Ensembl genes were retained for further
analysis. The same individuals had also been genotyped with
Illumina’s 1M-Duo and 1.2M-Duo chips; 865,544 SNPs with
MAF.1% passed quality check (QC). The overlapping set of
successfully genotyped samples with available expression data
amounted to 156 individuals for LCL (30 MZ pairs, 37 DZ pairs,
22 singletons), 160 for skin (31 MZ pairs, 37 DZ pairs, 24 singletons)
and 166 for fat (31 MZ pairs, 40 DZ pairs, 24 singletons). This final
dataset was used for eQTL analysis.
We tested for SNP-gene expression associations (eQTLs)
separately in each tissue. We considered only unrelated individuals
at a time by separating twins from the same pair and thus
performing two independent eQTL analyses per tissue. This study
design, hereafter named Matched Co-Twin Analysis (MCTA),
permits immediate replication and validation of eQTL discoveries.
We used Spearman Rank Correlation (SRC) to detect associations
and restricted our search to cis effects located within 1Mb on either
side of a gene’s transcription start site (TSS). Statistical significance
was assessed at different thresholds using permutations (10,000 per
gene) [5]. We detected an abundance of cis eQTLs (Table S1A)
per tissue at a comparable rate to other studies of similar sample
size [5,7]. The reported eQTLs appear robust as they replicate
well between individuals of the two co-twin groups per tissue. We
measured the eQTL overlap in a continuous fashion by taking the
significant SNP-gene associations from one co-twin set and
estimating the proportion of true associations (p1 statistic [23],
see Materials and Methods) on the distribution of corresponding p-
values in the reciprocal co-twin validation set. High levels of eQTL
replication were observed across co-twins, with a mean p1 of 0.93
in skin and 0.98 in LCL and fat (Table 1). We also measured the
estimated proportion of true positives among the subset of genes
that did not replicate in the co-twin at the same threshold. This too
is high (p1=0.84 for skin and 0.94 for LCL and fat), suggesting
that exact overlap of genes at a given permutation threshold (PT) is
an underestimate of eQTL replication due to winner’s curse. In
other words, we detected eQTLs in the co-twin that clearly
replicated the initial findings, but at p-values that marginally
missed the initial discovery threshold. To further confirm the
robustness of our discoveries, we overlapped the MuTHER LCL
results with available eQTL data from two recent independent
studies. 40% of the genes for which we detect LCL eQTLs overlap
Author Summary
Regulation of gene expression is a fundamental cellular
process determining a large proportion of the phenotypic
variance. Previous studies have identified genetic loci
influencing gene expression levels (eQTLs), but the
complexity of their tissue-specific properties has not yet
been well-characterized. In this study, we perform cis-eQTL
analysis in a unique matched co-twin design for three
human tissues derived simultaneously from the same set
of individuals. The study design allows validation of the
substantial discoveries we make in each tissue. We explore
in depth the tissue-dependent features of regulatory
variants and estimate the proportions of shared and
specific effects. We use continuous measures of eQTL
sharing to circumvent the statistical power limitations of
comparing direct overlap of eQTLs in multiple tissues. In
this framework, we demonstrate that 30% of eQTLs are
shared among tissues, while 29% are exclusively tissue-
specific. Furthermore, we show that the fold change in
expression between eQTL genotypic classes differs be-
tween tissues. Even among shared eQTLs, we report a
substantial proportion (10%–20%) of significant tissue
differences in magnitude of these effects. The complexities
we highlight here are essential for understanding the
impact of regulatory variants on complex traits.
Table 1. Cis eQTL discoveries (number of genes) per tissue at 10
23 PT.
Number of significant genes at 10
23 PT
SRC analysis SRC-FA analysis
Twin 1 Twin 2 Shared Replication (Mean p1) Twin 1 Twin 2 Shared Replication (Mean p1)
LCL 509 556 363 0.98 1064 1220 781 0.97
SKIN 238 231 132 0.93 532 542 338 0.95
FAT 462 488 304 0.98 1052 1070 735 0.97
Results from both the Spearman Rank Correlation (SRC) and Factor Analysis (SRC-FA) presented. Proportion of replicating signals calculated as the mean co-twin p1
estimates from the p-value distribution of same SNP-gene associations in the reciprocal twin set.
doi:10.1371/journal.pgen.1002003.t001
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(CEU) (Stranger et al. submitted). Likewise, 36% of the cis
associations detected by Gibson et. al. in leukocytes derived from
194 southern Moroccan individuals [24] overlap with genes
reported in our study. Given the differences in gender distribution,
sample preparation or even cell-type tested (LCL versus leukocytes)
across these studies, the gene overlap observed is reassuring.
The observed variation in gene expression is not entirely due to
genetic effects. Experimental noise and environmental conditions
also affect transcript levels in a global manner. Therefore, it is
desirable to remove the effects of such random variables and thus
increase the power to detect eQTLs. For this purpose, we
employed factor analysis (FA) on each tissue separately and
corrected for global latent effects on all individuals in each tissue
[25]. We fitted various parameters such as number of learned
factors and proportion of variance explained, in order to maximize
for replication of eQTLs per tissue between twin sets. After
performing standard SRC eQTL analysis on the factor-corrected
expression data (SRC-FA), we obtained a substantial improvement
in eQTL discovery at each of the standard permutation thresholds
used (Table S1B). The improvement (twice as many eQTLs at
10
23 PT) is consistent in all tissues. The high eQTL replication
between twin sets persists after FA, with an additional improve-
ment of true positives detection in skin: p1=0.95 (Table 1). As
expected, FA correction recovers the majority of the eQTLs
discovered with the initial analysis (90% of LCL and fat and 80%
of skin) ensuring that proximal genetic effects have not been
corrected out. The FA correction enabled the discovery of
additional signals (Table S2) likely representing real effects that
could not be detected initially due to low power. This is supported
by the significant overrepresentation of low association p-values
(p1=0.99, Figure 1) estimated in the uncorrected data for eQTLs
detected only after FA correction.
Direct tissue overlap of significant eQTLs supports an extensive
level of tissue-specificity for the three tissues, with very similar
proportions in both the SRC and SRC-FA analyses (Figure 2). In
the first co-twin set we discovered 858 eQTL genes (non-
redundant union) at 10
23 PT in all three tissues (Table 2). Of
these, 106 genes (12.35%) are shared across all tissues, 139 (16.2%)
are shared in at least two tissues and 613 genes (71.44%) are
detected in only one tissue. In skin we detect proportionally fewer
tissue-specific effects (10.02% of skin eQTLs are specific to skin at
10
23 PT), an observation likely due to tissue heterogeneity and
larger variety of present cell-types. SRC-FA results confirm the
estimated ,30% of eQTLs to be shared in at least two tissues
based on threshold eQTL discovery (Table S3).
Tissue-specific effects are largely not due to tissue-specific expression of
the underlying transcripts. We detected regulatory variants active only in
one tissue for genes that are expressed at high levels in the other two
tissues (Figure S1). The strength of tissue-specificity was investigated
further by performing a joint repeated-measures ANOVA analysis with
the tissue modelled as a categorical predictor variable (i.e. tissue type
comprised the repeated measure). We assessed the relationship to the
genotype by inspecting the SNP6 tissue interaction p-value term. As
expected, we detected a large enrichment of significant SNP6 tissue
interaction p-values for all associations (p1=0.56) with tissue-specific
effects having higher enrichment (p1=0.6) than shared ones (p1=0.41)
(Figure S2). The enrichment in the shared category suggests additional
attributes of tissue-specificity beyond statistical significance, as presented
in the succeeding fold change analysis.
The direction of allelic effects for shared eQTLs (10
23 and 10
22
PT) is consistent across the three given tissues (Figure S3). As
expected, for eQTLs significant in one tissue only the SRC
correlation coefficient rho (reflecting direction and magnitude of
effects) explains a substantially higher fraction of gene expression
variation in the tissue of discovery compared to the other two
tissues (identical SNP-gene associations - Figure S4). On the other
hand, the amount of expression variance explained by shared
eQTLs (10
23 PT) is comparable across tissues.
To refine regulatory signals and describe independently acting
variants, we mapped eQTLs to recombination hotspot intervals
and filtered markers in high LD (Materials and Methods). We
found that ,7% of the genes tested are regulated by more than
one independent cis eQTL, with similar estimates obtained from
the standard and factor eQTL analysis (Figure S5). For finer
comparison of eQTL effects, we conducted an analysis where
sharing was required for both the gene and the genomic interval
harboring the eQTL. This analysis yielded similar counts of tissue-
shared and specific effects (Tables S4, S5), suggesting that the vast
majority of shared genes also share regulatory variants across
tissues. Furthermore, as shown previously [7], we observed that
eQTLs cluster symmetrically around the TSS, with shared effects
being distributed tightly around the TSS and tissue-specific effects
spanning a greater range of distances (Figures S6, S7).
The results described so far are based on thresholds, which are
driven by statistical significance. Overlaps at these levels are heavily
dependent on power and affected by winner’s curse. In addition,
eQTLs sharing statistical significance may still have notable effect
differences on gene expression levels across tissues, with potentially
different biological consequences. Given these caveats, we exam-
ined tissue-specificity in a continuous manner by quantifying the
proportion of true positives estimated from the enrichment of low p-
values (p1). Specifically, the p-value distribution of significant SNP-
probe pairs (10
23 PT) from a reference tissue was investigated in the
other two tissues. The p-value distribution in the other tissues
indicates a high degree of tissue sharing (53 to 80%) both with the
SRC and SRC-FA, varying slightly depending on the reference
tissue in the comparison (Table S6). This suggests that there are
effect size differences (both fold change and amount of variance
explained) among tissues for the same regulatory variants, which is
the basis for the previously described higher eQTL tissue-specificity
estimates [7]. Overall, 29% of eQTLs (1-mean p1) are estimated
with the continuous approach to be tissue-specific, when comparing
the three tissues studied.
As described above, tissue overlap of eQTLs should encompass
not only sharing of a statistically significant regulatory effect, but
also a similar effect size (fold change in expression) of that variant
across tissues. In this respect, we report the fold change as the
difference between the gene expression means of the heterozygous
and major homozygous genotypic classes. Within the same tissue,
the two co-twin sets are only slightly different in their fold change
estimates. These minor differences reflect most probably the
winner’s curse effect (0.96 Pearson’s correlation of fold change
between Twin 1 and Twin 2 in LCL, 0.93 in skin and 0.93 in fat -
Figure 3, Figures S8, S9). The difference in estimated effect size is
much more apparent however across tissues (e.g. LCL eQTLs
have a 0.69 and 0.77 fold change correlation with skin and fat
eQTLs respectively, skin eQTLs have a 0.69 fold change
correlation with fat eQTLs). This is largely a consequence of
eQTL tissue-specificity, but a small effect of winner’s curse is also
expected (as observed in the comparison of co-twin sets).
Furthermore, additional possible hidden tissue-specific effects are
implied by the fact that shared eQTLs (at the same threshold of
significance) don’t always share the same effect size across tissues
(LCL fold change correlation of 0.78 in skin and 0.84 in fat for
shared eQTLs i.e. up to 20% difference in fold change magnitude
between tissues compared to within-tissue difference). This
suggests that even statistically tissue-shared eQTLs have additional
Regulatory Variation across Multiple Human Tissues
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tissues does not guarantee similar magnitude of consequences.
Discussion
WehaveperformedeQTLanalysisinonecell-line(LCL)andtwo
primary tissues of clinical importance (skin – previously unchar-
acterized and fat). For each tissue we report robust eQTLs
replicating in independent samples with identical (MZ) or on
average 50% similar (DZ) genetic background using a matched co-
twin design (MCTA). To further increase our power to detect
eQTLs and uncover smaller genetic effects, we applied factor
analysis accounting for global variance components in the data. We
refined our signals to detect independently acting cis eQTLs and for
Figure 1. P-value distribution of cis eQTLs (10
23 PT) gained with FA correction in the uncorrected data. The significant
overrepresentation of low p-values for the new eQTLs (p1=0.99) shows that the signal existed in the uncorrected data but wasn’t called significant
due to low power. In each tissue, the exact SNP-gene combinations (eQTLs) tested are presented for both co-twin sets (Twin 1—first column, Twin
2—second column).
doi:10.1371/journal.pgen.1002003.g001
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these variants are shared across tissues, they also share the same
direction of allelic effects and map to the same recombination
hotspot interval. Using threshold-based criteria, tissue overlap of
eQTLs supports a large degree of tissue-specificity for the three
tissues studied. However, this estimate is dependent on power and
we therefore putforth a continuous measureof tissue-specificity that
provides a refined view of the decay of statistical significance as well
as fold change effect on gene expression. Using this approach we
observed a significant overrepresentation of low p-values in all
Figure 2. Proportion of tissue shared and tissue-specific eQTLs (10
23 PT) from the SRC analysis and SRC-FA respectively. Both
methods reveal similarly high extents of tissue-specificity. Skin specific eQTLs of smaller effects are harder to detect due to low power.
doi:10.1371/journal.pgen.1002003.g002
Table 2. Tissue-shared and tissue-specific gene associations (10
23 PT), SRC analysis.
Twin 1 Twin 2
10
23 PT % total Overlap 10
23 PT % total
3 tissues LCL-SKIN-FAT 106 12.35 78 102 11.02
2 tissues only LCL-SKIN 19 2.21 4 12 1.29
LCL-FAT 93 10.84 52 107 11.56
SKIN-FAT 27 3.15 11 26 2.81
1 tissue only LCL 291 33.92 150 335 36.18
SKIN 86 10.02 17 91 9.82
FAT 236 27.50 103 253 27.32
Total significant LCL 509 363 556
SKIN 238 132 231
FAT 462 304 488
Union of total significant 858 100 563 926 100
doi:10.1371/journal.pgen.1002003.t002
Regulatory Variation across Multiple Human Tissues
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statistically significant regulatory effects, some yet to be discovered
with bigger sample sizes. However, we also observed significant
eQTLs at the same threshold exhibiting differential fold changes in
expression between genotypes across tissues. These cases represent
tissue-specific effects as well, since differential fold change in
expression is likely to have different biological consequences.
Overall biological interpretation of regulatory effects - much like
in the case of complex traits – is tissue-dependent, highlighting the
value of multiple tissue expression datasets. Understanding such
complexities and context-dependent effects in the genetic architec-
ture of gene expression and other cellular phenotypes is essential for
the interpretation of the biological properties of disease causing
variants.
Figure 3. Fold change within twins and across tissues for LCL eQTLs (10
23 PT, SRC) discovered in Twin 1. The plotted fold change on
the X-and Y-axes was calculated as the difference in mean expression of the heterozygous and major homozygous genotypic classes. For each
pairwise tissue comparison, the Pearson’s correlation coefficient between fold changes is shown.
doi:10.1371/journal.pgen.1002003.g003
Regulatory Variation across Multiple Human Tissues
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All samples and information were collected with written and
signed informed consent. The project has been approved by the
local ethics committees of all institutions involved.
Sample collection
All individuals recruited in this study were Caucasian female
twins aged between 40 and 87 years old (mean age 62). Skin punch
biopsies (N=196) were taken from a relatively photo-protected
area adjacent and inferior to the umbilicus. The fat sample was
then carefully dissected from the same skin biopsy incision. A
peripheral blood sample to generate lymphoblastoid cell lines
(LCL) was taken contemporaneously. For a full description of the
biopsy technique see Text S1.
Gene expression measurements and genotyping
RNA levels were measured in LCL, skin and fat using Illumina’s
whole-genome expression array HumanHT-12 version 3 as
previously described [5]. Each sample had three technical
replicates. Illumina’s v3 probes were mapped to unique Ensembl
gene IDs by combining and cross-checking two methods. The first
approach used Illumina’s probe annotation to RefSeq IDs. These
were further queried with BioMart (Ensembl 54) for corresponding
Ensembl genes. RefSeq IDs mapping to multiple EnsGenes were
excluded. The second approach used BLAT to map the 50-mer
probe sequences to Ensembl transcripts and to extract genomic
locations matching for all 50 bases of the probe sequence. Probes
with unique perfect match to the genome and corresponding
transcripts matching to the same genes were kept. The union of
the two mappings after excluding 196 conflictingly matching
probes resulted in 27,499 probes corresponding to 18,170
autosomal genes available for association analysis.
Genotyping has been performed in parallel using Illumina’s
1M-Duo and 1.2M-Duo custom chips on different subsets of
individuals. Before further filtering, there were 106 samples with
call rate (CR)$0.90 on the 1.2M and 88 samples with CR$0.90
on the 1M chip. Combined intensity files were created for
Illuminus [26] by retaining on a per-chromosome basis only SNPs
common to both chips. Additionally, any SNPs that moved
position between the two chips were removed. Following further
quality checks (Hardy-Weinberg p.10
24, MAF.1%), 865,544
SNPs were kept for analysis.
The overlapping set of successfully genotyped samples with
available expression data amounted to 156 (LCL), 160 (skin) and
166 (fat) individuals.
Post-experimental normalization of gene expression data
Log2 - transformed expression signals were normalized
separately per tissue as follows: quantile normalization was
performed across the 3 replicates of each individual followed by
quantile normalization across all individuals.
Genotype-gene expression associations and multiple
testing correction
The eQTL analysis was done separately for each tissue. Within
each tissue, twins from the same pair were separated by id in two
samples analyzed independently. This separation resulted in the
following sample size for LCL, skin and fat respectively: Twin 1
(74, 76, 79) and Twin 2 (82, 84, 87). Associations between SNP
genotypes and normalized expression values were conducted using
Spearman Rank Correlation (SRC). We considered only SNPs in
cis, i.e. within a 1MB window from the TSS. We assess the
statistical significance of the nominal associations using permuta-
tions as previously described [5]. We call an eQTL significant at
10
23 permutation threshold (PT) if the nominal association P-
value is greater than the 0.001 tail of the minimal P-value
distribution resulting from the SNP’s associations with 10,000
permuted sets of expression values for each gene.
Factor analysis
We applied a Bayesian factor analysis model [25] to the
expression data in each tissue. This approach uses an unsupervised
linear model to account for global variance components in the
data, and yields a residual expression dataset that can be used in
further analysis.
We tested a wide range of parameter settings for the model,
controlling the amount of variance explained by it. This was
achieved by setting the parametersofthe priordistributions for gene
expression precision (inverse variance) and factor weight precision.
These random variables are modelled using Gamma distributions,
thus we varied their natural exponential family parameters - the
prior mean and number of prior observations. We varied the prior
mean from 10
26 to 10
22, and number of prior observations from
N*10
23 to N, whereN is the numberof observations from data, and
learned 120 latent factors. In the subsequent analysis, we used for
each tissue the residual dataset that gave the best eQTL overlap
between the two twin samples. The prior values used for each
dataset are given in Table S7. The eQTL analysis on the corrected
expression data was performed identically to the standard analysis:
SRC followed by permutation testing.
Proportion of true positives from p-value distribution
For quantifying eQTL replication and tissue sharing in a
continuous way, we used Storey’s QVALUE software [23]
(implemented in the R package qvalue 1.20.0, default recom-
mended settings). The program takes a list of p-values and
computes their estimated p0 - the proportion of features that are
truly null - based on their distribution (the assumption used is that
p-values of truly alternative cases tend to be close to zero, while p-
values of null features will be uniformly distributed among [0,1]).
The quantity p1=12p0 estimates the lower bound of the
proportion of truly alternative features, i.e. the proportion of true
positives (TP). Replication and sharing between two samples is
reported as the proportion of TP (p1) estimated from the p-value
distribution of independent eQTLs discovered in sample 1 in the
second sample (exact SNP-probe combinations are tested).
Recombination hotspot interval mapping and LD
filtering
We refined the eQTL signals in order to characterize likely
independent effects per gene. For this purpose, we mapped all
common autosomal SNPs to recombination hotspot intervals as
defined by McVean et.al [27]. We map significant eQTLs to
recombination hotspot intervals and save the most significant SNP
per gene. For each gene, SNPs resulting from this mapping are in
addition filtered for LD in a pairwise manner (for each pair with
D9.0.5 the least significant SNP is ignored). This filtering ensures
that true shared effects (interval-gene combinations) are compared
and not just genes.
Supporting Information
Figure S1 Median expression values of tissue-specific genes in
the tissue of discovery and the other two tissues. Tissue-specific
effects are not restricted to genes expressed in a tissue-specific
manner.
10.1371/journal.pgen.1002003.s001(TIFF)
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measures ANOVA for all, shared and tissue-specific eQTLs
respectively. Greater enrichment of significant SNP6tissue p-
values is observed for tissue-restricted effects.
10.1371/journal.pgen.1002003.s002(TIFF)
Figure S3 eQTLs (10
22 PT, SRC) shared in all three tissues
tested have the same direction of allelic effect (SRC rho) across
tissues.
10.1371/journal.pgen.1002003.s003(TIFF)
Figure S4 Cumulative SRC rho distribution across tissues for
tissue-specific and shared eQTLs (10
23 PT, Twin1). eQTLs
discovered in one tissue only have distinctively higher variance in
the tissue of discovery compared to shared effects.
10.1371/journal.pgen.1002003.s004(TIFF)




Figure S6 Distribution of independent cis eQTLs (10
23 PT,
SRC) around TSS, Twin 1.
10.1371/journal.pgen.1002003.s006(TIFF)
Figure S7 Distribution of independent cis eQTLs gained with
FA correction (10
23 PT) around TSS, Twin 1.
10.1371/journal.pgen.1002003.s007(TIFF)
Figure S8 Fold change within twins and across tissues for SKIN
eQTLs (10
23 PT, SRC) discovered in Twin 1. Fold change was
calculated as the difference in mean expression of the heterozygous
and major homozygous genotypic classes. For each pairwise tissue
comparison, the Pearson’s correlation coefficient between fold
changes is shown.
10.1371/journal.pgen.1002003.s008(TIFF)
Figure S9 Fold change within twins and across tissues for FAT
eQTLs (10
23 PT, SRC) discovered in Twin 1. Fold change was
calculated as the difference in mean expression of the heterozygous
and major homozygous genotypic classes. For each pairwise tissue
comparison, the Pearson’s correlation coefficient between fold
changes is shown.
10.1371/journal.pgen.1002003.s009(TIFF)
Table S1 Cis eQTL associations with SRC and SRC-FA.
10.1371/journal.pgen.1002003.s010(DOC)
Table S2 eQTL recovery with FA. FA correction recovers the
majority of eQTLs from the SRC analysis and adds twice as many
discoveries.
10.1371/journal.pgen.1002003.s011(DOC)




Table S4 Tissue-shared and tissue-specific interval-gene associ-
ations (10
23 PT), SRC analysis.
10.1371/journal.pgen.1002003.s013(DOC)




Table S6 Continuous estimates of tissue sharing by enrichment
of low p-values (p1) of reference eQTLs (SNP-probes 10
23 PT) in
the other two secondary tissues.
10.1371/journal.pgen.1002003.s015(DOC)
Table S7 FA weight and noise prior values used for each tissue.
10.1371/journal.pgen.1002003.s016(DOC)
Text S1 Biopsy technique protocol.
10.1371/journal.pgen.1002003.s017(DOC)
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